Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Atropine for Drooling Control in Children With Cerebral Palsy
TCTR20241022002Phase 3Completed
- Sponsor
- University of Child Health Sciences and Children's Hospital, Lahore
- Start
- Sep 2024
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atropine in cerebral palsy (CP), hypersalivation, sponsored by University of Child Health Sciences and Children's Hospital, Lahore. Started Sep 2024; status: completed.
02
Drugs
atropine
03
Conditions
cerebral palsy (CP)hypersalivation
Beyond the preview
Go deeper on TCTR20241022002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241022002.